Boston Scientific Operating Income 2010-2025 | BSX
Boston Scientific annual/quarterly operating income history and growth rate from 2010 to 2025. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
- Boston Scientific operating income for the quarter ending March 31, 2025 was $922M, a 37% increase year-over-year.
- Boston Scientific operating income for the twelve months ending March 31, 2025 was $2.854B, a 15.78% increase year-over-year.
- Boston Scientific annual operating income for 2024 was $2.605B, a 11.18% increase from 2023.
- Boston Scientific annual operating income for 2023 was $2.343B, a 42.26% increase from 2022.
- Boston Scientific annual operating income for 2022 was $1.647B, a 37.48% increase from 2021.
| Boston Scientific Annual Operating Income (Millions of US $) |
|
|---|---|
| 2024 | $2,605 |
| 2023 | $2,343 |
| 2022 | $1,647 |
| 2021 | $1,198 |
| 2020 | $-79 |
| 2019 | $1,517 |
| 2018 | $1,506 |
| 2017 | $1,285 |
| 2016 | $447 |
| 2015 | $-283 |
| 2014 | $-301 |
| 2013 | $120 |
| 2012 | $-3,868 |
| 2011 | $904 |
| 2010 | $-656 |
| 2009 | $-894 |
| Boston Scientific Quarterly Operating Income (Millions of US $) |
|
|---|---|
| 2025-03-31 | $922 |
| 2024-12-31 | $679 |
| 2024-09-30 | $733 |
| 2024-06-30 | $520 |
| 2024-03-31 | $673 |
| 2023-12-31 | $586 |
| 2023-09-30 | $692 |
| 2023-06-30 | $514 |
| 2023-03-31 | $551 |
| 2022-12-31 | $401 |
| 2022-09-30 | $358 |
| 2022-06-30 | $422 |
| 2022-03-31 | $466 |
| 2021-12-31 | $180 |
| 2021-09-30 | $387 |
| 2021-06-30 | $262 |
| 2021-03-31 | $369 |
| 2020-12-31 | $51 |
| 2020-09-30 | $-206 |
| 2020-06-30 | $-70 |
| 2020-03-31 | $146 |
| 2019-12-31 | $209 |
| 2019-09-30 | $383 |
| 2019-06-30 | $384 |
| 2019-03-31 | $541 |
| 2018-12-31 | $318 |
| 2018-09-30 | $389 |
| 2018-06-30 | $391 |
| 2018-03-31 | $408 |
| 2017-12-31 | $319 |
| 2017-09-30 | $377 |
| 2017-06-30 | $225 |
| 2017-03-31 | $364 |
| 2016-12-31 | $140 |
| 2016-09-30 | $348 |
| 2016-06-30 | $-334 |
| 2016-03-31 | $293 |
| 2015-12-31 | $-227 |
| 2015-09-30 | $-299 |
| 2015-06-30 | $219 |
| 2015-03-31 | $24 |
| 2014-12-31 | $-493 |
| 2014-09-30 | $64 |
| 2014-06-30 | $-69 |
| 2014-03-31 | $197 |
| 2013-12-31 | $127 |
| 2013-09-30 | $103 |
| 2013-06-30 | $220 |
| 2013-03-31 | $-330 |
| 2012-12-31 | $117 |
| 2012-09-30 | $-594 |
| 2012-06-30 | $-3,587 |
| 2012-03-31 | $196 |
| 2011-12-31 | $171 |
| 2011-09-30 | $174 |
| 2011-06-30 | $237 |
| 2011-03-31 | $322 |
| 2010-12-31 | $348 |
| 2010-09-30 | $251 |
| 2010-06-30 | $231 |
| 2010-03-31 | $-1,486 |
| 2009-12-31 | $-1,231 |
| 2009-09-30 | $51 |
| 2009-06-30 | $275 |
| 2009-03-31 | $11 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $145.814B | $16.747B |
| Boston Scientific Corporation manufactures medical devices and products used in various interventional medical specialties worldwide. The company has adopted the organic as well as inorganic routes for success. Boston Scientific currently has 3 global reportable segments - Cardiovascular, Rhythm and Neuro and MedSurg. While Cardiovascular includes Interventional Cardiology and Peripheral Interventions, Rhythm and Neuro comprises Cardiac Rhythm Management, Electrophysiology and Neuromodulation. The MedSurg group comprises 2 sub segments, viz. Endoscopy, Urology and Pelvic Health. Boston Scientific markets a broad portfolio of internally-developed and self-manufactured drug eluting stents including the Promus PREMIER, Promus Element and Promus Element Plus everolimus-eluting stents. Within the CRM segment, the company deals with implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $237.401B | 28.55 |
| Stryker (SYK) | United States | $145.229B | 30.37 |
| EssilorLuxottica (ESLOY) | France | $130.605B | 0.00 |
| Medtronic (MDT) | Ireland | $113.492B | 16.09 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.916B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.556B | 28.23 |
| ResMed (RMD) | United States | $36.981B | 27.78 |
| Agilent Technologies (A) | United States | $33.778B | 22.02 |
| GE HealthCare Technologies (GEHC) | United States | $33.476B | 15.89 |
| Terumo (TRUMY) | Japan | $27.213B | 35.35 |
| Koninklijke Philips (PHG) | Netherlands | $22.201B | 15.96 |
| Insulet (PODD) | United States | $21.367B | 83.87 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.451B | 11.85 |
| Baxter (BAX) | United States | $16.093B | 12.02 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.187B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.076B | 0.00 |
| Demant (WILYY) | Denmark | $8.854B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.325B | 22.01 |
| Lantheus Holdings (LNTH) | United States | $5.545B | 13.99 |
| Prestige Consumer Healthcare (PBH) | United States | $4.207B | 18.80 |
| Perrigo (PRGO) | Ireland | $3.746B | 9.49 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Haemonetics (HAE) | United States | $3.428B | 15.61 |
| ICU Medical (ICUI) | United States | $3.258B | 24.02 |
| Envista Holdings (NVST) | United States | $3.198B | 26.58 |
| GN Store Nord (GNNDY) | Denmark | $2.319B | 19.20 |
| QuidelOrtho (QDEL) | United States | $2.021B | 13.90 |
| LeMaitre Vascular (LMAT) | United States | $1.839B | 41.10 |
| AtriCure (ATRC) | United States | $1.600B | 0.00 |
| Acuren (TIC) | United States | $1.308B | 0.00 |
| Neogen (NEOG) | United States | $1.220B | 15.61 |
| AdaptHealth (AHCO) | United States | $1.187B | 12.05 |
| BioLife Solutions (BLFS) | United States | $1.107B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.061B | 23.86 |
| Phibro Animal Health (PAHC) | United States | $0.993B | 12.70 |
| Kestra Medical Technologies (KMTS) | United States | $0.963B | 0.00 |
| InMode (INMD) | Israel | $0.888B | 8.95 |
| CeriBell (CBLL) | United States | $0.657B | 0.00 |
| Evolus (EOLS) | United States | $0.656B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.637B | 0.00 |
| Owens & Minor (OMI) | United States | $0.616B | 5.11 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.576B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.547B | 0.00 |
| Valneva SE (VALN) | France | $0.523B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.419B | 0.00 |
| Surmodics (SRDX) | United States | $0.416B | 0.00 |
| SNDL (SNDL) | Canada | $0.355B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.351B | 12.92 |
| Aurora Cannabis (ACB) | Canada | $0.342B | 60.90 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.329B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.281B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.268B | 22.60 |
| Sanuwave Health (SNWV) | United States | $0.265B | 0.00 |
| Cerus (CERS) | United States | $0.262B | 0.00 |
| ZimVie (ZIMV) | United States | $0.258B | 11.75 |
| Sanara MedTech (SMTI) | United States | $0.255B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.251B | 0.00 |
| Quanterix (QTRX) | United States | $0.240B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.219B | 0.00 |
| Biote (BTMD) | United States | $0.216B | 6.08 |
| Brainsway (BWAY) | Israel | $0.216B | 57.10 |
| TriSalus Life Sciences (TLSI) | United States | $0.208B | 0.00 |
| Omeros (OMER) | United States | $0.208B | 0.00 |
| Organigram Global (OGI) | Canada | $0.197B | 0.00 |
| High Tide (HITI) | Canada | $0.189B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.18 |
| Verano Holdings (VRNOF) | United States | $0.180B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.143B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.134B | 16.51 |
| Jin Medical (ZJYL) | China | $0.109B | 0.00 |
| MacroGenics (MGNX) | United States | $0.098B | 0.00 |
| Veru (VERU) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| Fonar (FONR) | United States | $0.090B | 11.60 |
| Quipt Home Medical (QIPT) | United States | $0.089B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| Agape ATP (ATPC) | $0.077B | 0.00 | |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.067B | 0.00 |
| Apyx Medical (APYX) | United States | $0.065B | 0.00 |
| Zynex (ZYXI) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Modular Medical (MODD) | United States | $0.043B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 57.29 |
| United-Guardian (UG) | United States | $0.038B | 13.02 |
| Rockwell Medical (RMTI) | United States | $0.033B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.020B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| Safety Shot (SHOT) | United States | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.013B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.012B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |